SecBot SecBot
PRESS-RELEASE ·Filed Mar 4, 2026

CTMX

CytomX Therapeutics Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should await the actual earnings release and call for material data. No trading action is warranted based on this announcement alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$5.07
T+0 close · Mar 4, 2026 · via day close
Latest settled
−26.82%
T+60 · $3.71
Vs SPY
−36.91%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 4 $5.07entry
  2. T+1 · 9mo ago −5.92%α −5.34% · $4.77
  3. T+5 · 8mo ago −3.75%α −2.41% · $4.88
  4. T+20 · 8mo ago −10.06%α −5.64% · $4.56
  5. T+60 · 6mo ago −26.82%α −36.91% · $3.71
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CytomX Therapeutics announced it will report full year 2025 financial results on March 16, 2026, before markets open, followed by a conference call. The press release contains no financial data, forward-looking results, or operational updates beyond the announcement of the earnings event.

Key Facts

  • CytomX Therapeutics (CTMX) will report full year 2025 financial results on March 16, 2026, before market open.
  • Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on the same day.
  • No financial results, guidance, or material operational updates were disclosed in this press release.
  • The release serves solely as a scheduling announcement for upcoming earnings.

Financial Impact

No financial data disclosed

Risk Factors

  • Earnings could miss expectations given lack of pre-announcement or positive signaling.
  • Biotech stocks like CTMX often experience volatility around earnings, especially with no forward guidance provided.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3249296

Track record

10 reports on CTMX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 2/10 Entry $1.98 Now $1.99 +0.25% settles Feb 8
  2. Nov 5, 202611d ago Press Release Bearish 5/10 No price data
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $2.19 Now $1.99 −9.36% settles Feb 4
  4. Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $2.36 Now $1.99 −15.89% settles Jan 26
  5. Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $2.94 Now $1.99 −32.48% settles Dec 16
  6. Jun 22, 202621w ago 8-K Neutral 3/10 Entry $3.15 to $2.77 Now $1.99 −36.98% ▼ −12.22% −15.47% vs SPY
  7. Mar 17, 202634w ago Press Release Neutral 6/10 Entry $4.40 to $2.98 Now $1.99 −54.89% ▼ −32.27% −43.80% vs SPY
  8. Mar 16, 202635w ago Press Release Bearish 7/10 Entry $5.45 to $2.98 Now $1.99 +63.58% ▲ +45.32% +55.18% vs SPY
  9. Mar 16, 202635w ago Press Release Mixed 6/10 Entry $6.75 to $2.94 Now $1.99 −70.59% ▼ −56.44% −66.93% vs SPY
  10. Mar 4, 202636w ago Press Release Neutral 3/10 Viewing Entry $5.07 to $3.71 Now $1.99 −60.85% ▼ −26.82% −36.91% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 4, 2026